Atrophy

Definition: decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Synonyms (terms occurring on more labels are shown first): atrophy

More information: PubMed search and possibly Wikipedia or Medpedia

Proteins predicted to cause Atrophy: NR3C1 (activation), NR3C1 (2 predictions in total)

Drugs with this side effect goserelin: 33% glatiramer acetate: infrequent, frequent diclofenac: 3.85% - 4% azilect: infrequent valproic acid: postmarketing flurandrenolide: postmarketing lamotrigine: rare mycophenolic acid: postmarketing omeprazole: postmarketing paroxetine: rare, postmarketing pergolide mesylate: rare testosterone: postmarketing tizanidine: rare venlafaxine: rare vigabatrin: postmarketing acitretin: postmarketing fluticasone propionate: postmarketing voriconazole: postmarketing pregabalin: rare amcinonide beclomethasone dipropionate busulfan calcipotriene carbamazepine chlorambucil chloroquine cyclophosphamide desoximetasone dexamethasone cyproterone acetate fentanyl diflorasone fluocinolone acetonide fluocinonide gentamicin halcinonide hydrocortisone hydrocortisone butyrate hydroxychloroquine hydroxyurea isoniazid lamivudine leuprolide acetate lomustine alkeran methylprednisolone nilutamide oxymetholone penicillamine prednisolone prednisone reserpine ropinirole sumatriptan (sumatriptan succinate) triamcinolone unoprostone isopropyl vincristine nandrolone medroxyprogesterone acetate desonide clocortolone lithium cation fludrocortisone vecuronium bromide buserelin (buserelin acetate) prednicarbate relpax mometasone furoate reyataz sitaxsentan sodium alclometasone dipropionate halobetasol pimecrolimus degarelix synarel histrelin

Drugs with this indication estradiol levothyroxine liothyronine doxorubicin hydrochloride cyanocobalamin risedronate sodium thalidomide oxandrolone desmopressin acetate estrogens, conjugated clobetasol hydroxocobalamin cosyntropin